EFSA rejects two new 13.5 claims on ‘transit’ and ‘vaginal moisture’
date:Sep 28, 2012
ERM SC,Bifidobacterium longum R0175 and Lactobacillus helveticus R0052.

In response to the application the NDA panel said it considered the information provided by Vivatech to be insufficient to establish that Saccharomyces cerevisiae subsp. cerevisiaeUVAFERM SC was sufficiently characterised.

The Panel considers that if in a combination of several microorganisms and/or ingredients one microorganism or ingredient used in the combination is not sufficiently characterised, then the combination i
4/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/27 22:52